Verified factor-similar pair

SFLO vs XTN

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB
Similarity score
83
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • SFLO has the higher backtested relative Sharpe (1.106 vs 0.668).
  • XTN has the lower published fee (0.35% vs 0.56%).
  • SFLO has the stronger regression fit (adjusted R-squared 0.836 vs 0.788).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

SFLO

VictoryShares Small Cap Free Cash Flow ETF
SMB
Adj. R2
0.836
Rel. Sharpe
1.106
Mkt beta
1.04
AUM
US$511M
MER
0.56%
Valuation
118

XTN

State Street SPDR S&P Transportation ETF
SMB
Adj. R2
0.788
Rel. Sharpe
0.668
Mkt beta
1.20
AUM
US$244M
MER
0.35%
Valuation
118

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
SFLO
+0.62
|t|
+4.0
XTN
+0.57
|t|
+5.5
diff +0.05
HML
SFLO
+0.27
|t|
+1.4
XTN
+0.16
|t|
+1.6
diff +0.11
RMW
SFLO
+0.08
|t|
+0.5
XTN
+0.11
|t|
+0.9
diff -0.03
CMA
SFLO
+0.14
|t|
+0.7
XTN
+0.11
|t|
+0.7
diff +0.04
UMD
SFLO
-0.20
|t|
-1.6
XTN
-0.11
|t|
-1.6
diff -0.09

Why This Pair Matches

Exposure level
83
Exposure shape
99
Mkt beta diff
0.16
Rel. Sharpe diff
0.439

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

SFLO fund page XTN fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.